Matthew Thomas Harper (Matthew T Harper)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Pulmonary Embolism

Antiplatelet Therapy

Top Venues

Research and practice in thrombosis and haemostasis

Journal of thrombosis and haemostasis : JTH

British journal of pharmacology

University of Cambridge

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Cambridge

United Kingdom

Senior Lecturer :: Department of Pharmacology

Publications

Sarah L Millington-Burgess, Matthew Thomas Harper
Maintaining flippase activity in procoagulant platelets is a novel approach to reducing thrombin generation. Journal of thrombosis and haemostasis : JTH 20 (4) (2022)
Jess Berry, Matthew Thomas Harper
Protease-activated receptor antagonists prevent thrombosis when dual antiplatelet therapy is insufficient in an occlusive thrombosis microfluidic model. Research and practice in thrombosis and haemostasis 6 (3) (2022)
Sarah Louise Millington-Burgess, Arkadiusz M Bonna, Taufiq Rahman, Matthew Thomas Harper
Ethaninidothioic acid (R5421) is not a selective inhibitor of platelet phospholipid scramblase activity. British journal of pharmacology 177 (17) (2020)